An essential drug list will be pha-sed in in South Africa from April 1, as part of a radical overhaul of the country's drug policy for state-appro-ved health care, Health Minister Nkosaz-ana Zuma has announced, and she challenged the drug industry to assist the government in holding down the runaway cost of medicines.
A committee to monitor and regulate prices will also be set up, while the EDL, part of the National Drug Policy, will restrict the number of available drugs on the basis of cost advantage and efficiency.
South African drug prices are among the highest in the world, said Dr Zuma, and increases will have to be regulated. Where prices are excessive, the state will turn to cheaper parallel imports. Generic substitution will be promoted by requiring prescriptions to use generic names, but patients will be able to pay more themselves for the dearer branded product.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze